Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Universal Allogeneic CAR T-cells”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Early research (Phase 1)Looking for participantsNCT06733610
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.

Who this might be right for
Autoimmune Hemolytic AnemiaCD19/BCMA CAR T-cellsUniversal Allogeneic CAR T-cells
Institute of Hematology & Blood Diseases Hospital, China 15
Very early researchLooking for participantsNCT06653023
What this trial is testing

Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer

Who this might be right for
HCC - Hepatocellular CarcinomaNSCLC (Advanced Non-small Cell Lung Cancer)
Wondercel Biotech (ShenZhen) 60
Testing effectiveness (Phase 2)Looking for participantsNCT05607420
What this trial is testing

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Cellectis S.A. 80
Early research (Phase 1)Looking for participantsNCT07315087
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSSc-Systemic SclerosisIIM- Idiopathic Inflammatory Myopathies+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Looking for participantsNCT04150497
What this trial is testing

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Cellectis S.A. 52
Very early researchNot Yet RecruitingNCT07392528
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMultiple SclerosisMyasthenia Gravis
Tianjin Huanhu Hospital 15
Not applicableActive Not RecruitingNCT07155369
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
The Affiliated Hospital of Xuzhou Medical University 18
Early research (Phase 1)Looking for participantsNCT06941129
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Inflammatory Myopathy+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)UnknownNCT05679687
What this trial is testing

ThisCART19A Bridging to alloHSCT for R/R B-ALL

Who this might be right for
CARRefractory Acute Lymphoblastic LeukemiaRelapsed Adult ALL
The First Affiliated Hospital of Soochow University 20
Very early researchLooking for participantsNCT06939166
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia GravisMultiple Sclerosis+2 more
Tianjin Huanhu Hospital 12
Very early researchLooking for participantsNCT06920433
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Zhejiang University 18
Early research (Phase 1)UnknownNCT05691153
What this trial is testing

ThisCART19A for B-NHL Relapsed After Auto-CAR T

Who this might be right for
CARB Cell LymphomaRelapsed Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 20
Very early researchLooking for participantsNCT06653010
What this trial is testing

Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer

Who this might be right for
CRC (Colorectal Cancer)Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen) 30
Not applicableLooking for participantsNCT05988216
What this trial is testing

Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Bioray Laboratories 12
Not applicableLooking for participantsNCT07248176
What this trial is testing

Universal CAR-T Cell Therapy for MM

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma, Refractory
Bioray Laboratories 6
Early research (Phase 1)Not Yet RecruitingNCT06978738
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAutoimmune Hemolytic AnemiaMyasthenia Gravis+4 more
Changzhou No.2 People's Hospital 18
Very early researchNot Yet RecruitingNCT06920446
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed / Refractory Autoimmune Hemolytic Anemia
Zhejiang University 18
Early research (Phase 1)Active Not RecruitingNCT04093596
What this trial is testing

Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Allogene Therapeutics 132
Very early researchNot Yet RecruitingNCT07410377
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory Myopathy
The Affiliated Hospital of Xuzhou Medical University 15
Very early researchNot Yet RecruitingNCT06933563
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Zhejiang University 18
Load More Results